Adult mice generated from induced pluripotent stem cells - PubMed (original) (raw)
. 2009 Sep 3;461(7260):91-4.
doi: 10.1038/nature08310.
Affiliations
- PMID: 19672243
- DOI: 10.1038/nature08310
Adult mice generated from induced pluripotent stem cells
Michael J Boland et al. Nature. 2009.
Abstract
Recent landmark experiments have shown that transient overexpression of a small number of transcription factors can reprogram differentiated cells into induced pluripotent stem (iPS) cells that resemble embryonic stem (ES) cells. These iPS cells hold great promise for medicine because they have the potential to generate patient-specific cell types for cell replacement therapy and produce in vitro models of disease, without requiring embryonic tissues or oocytes. Although current iPS cell lines resemble ES cells, they have not passed the most stringent test of pluripotency by generating full-term or adult mice in tetraploid complementation assays, raising questions as to whether they are sufficiently potent to generate all of the cell types in an organism. Whether this difference between iPS and ES cells reflects intrinsic limitations of direct reprogramming is not known. Here we report fertile adult mice derived entirely from iPS cells that we generated by inducible genetic reprogramming of mouse embryonic fibroblasts. Producing adult mice derived entirely from a reprogrammed fibroblast shows that all features of a differentiated cell can be restored to an embryonic level of pluripotency without exposure to unknown ooplasmic factors. Comparing these fully pluripotent iPS cell lines to less developmentally potent lines may reveal molecular markers of different pluripotent states. Furthermore, mice derived entirely from iPS cells will provide a new resource to assess the functional and genomic stability of cells and tissues derived from iPS cells, which is important to validate their utility in cell replacement therapy and research applications.
Comment in
- Ethical concerns over use of new cloning technique in humans.
Denker HW. Denker HW. Nature. 2009 Sep 17;461(7262):341. doi: 10.1038/461341b. Nature. 2009. PMID: 19759600 No abstract available.
Similar articles
- iPS cells produce viable mice through tetraploid complementation.
Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng F, Zhou Q. Zhao XY, et al. Nature. 2009 Sep 3;461(7260):86-90. doi: 10.1038/nature08267. Nature. 2009. PMID: 19672241 - Production of mice using iPS cells and tetraploid complementation.
Zhao XY, Lv Z, Li W, Zeng F, Zhou Q. Zhao XY, et al. Nat Protoc. 2010 May;5(5):963-71. doi: 10.1038/nprot.2010.61. Epub 2010 Apr 29. Nat Protoc. 2010. PMID: 20431542 - Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation.
Cho HJ, Lee CS, Kwon YW, Paek JS, Lee SH, Hur J, Lee EJ, Roh TY, Chu IS, Leem SH, Kim Y, Kang HJ, Park YB, Kim HS. Cho HJ, et al. Blood. 2010 Jul 22;116(3):386-95. doi: 10.1182/blood-2010-02-269589. Epub 2010 May 3. Blood. 2010. PMID: 20439621 - Viable fertile mice generated from fully pluripotent iPS cells derived from adult somatic cells.
Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Wang X, Wang L, Zeng F, Zhou Q. Zhao XY, et al. Stem Cell Rev Rep. 2010 Sep;6(3):390-7. doi: 10.1007/s12015-010-9160-3. Stem Cell Rev Rep. 2010. PMID: 20549390 Review. - The molecular mechanism of induced pluripotency: a two-stage switch.
Scheper W, Copray S. Scheper W, et al. Stem Cell Rev Rep. 2009 Sep;5(3):204-23. doi: 10.1007/s12015-009-9077-x. Epub 2009 Jun 24. Stem Cell Rev Rep. 2009. PMID: 19551525 Review.
Cited by
- Manipulating cell fate through reprogramming: approaches and applications.
Yagi M, Horng JE, Hochedlinger K. Yagi M, et al. Development. 2024 Oct 1;151(19):dev203090. doi: 10.1242/dev.203090. Epub 2024 Sep 30. Development. 2024. PMID: 39348466 Review. - The progress of induced pluripotent stem cells derived from pigs: a mini review of recent advances.
Neira JA, Conrad JV, Rusteika M, Chu LF. Neira JA, et al. Front Cell Dev Biol. 2024 Jun 24;12:1371240. doi: 10.3389/fcell.2024.1371240. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38979033 Free PMC article. Review. - Regulation of cell fate by cell imprinting approach in vitro.
Hasannejad F, Montazeri L, Mano JF, Bonakdar S, Fazilat A. Hasannejad F, et al. Bioimpacts. 2024;14(3):29945. doi: 10.34172/bi.2023.29945. Epub 2023 Nov 28. Bioimpacts. 2024. PMID: 38938752 Free PMC article. Review. - Functional sensory circuits built from neurons of two species.
Throesch BT, Bin Imtiaz MK, Muñoz-Castañeda R, Sakurai M, Hartzell AL, James KN, Rodriguez AR, Martin G, Lippi G, Kupriyanov S, Wu Z, Osten P, Izpisua Belmonte JC, Wu J, Baldwin KK. Throesch BT, et al. Cell. 2024 Apr 25;187(9):2143-2157.e15. doi: 10.1016/j.cell.2024.03.042. Cell. 2024. PMID: 38670072 - Integration-free induced pluripotent stem cells from three endangered Southeast Asian non-human primate species.
Bao Q, Tay NL, Lim CY, Chua DHH, Kee SK, Choolani M, Loh YH, Ng SC, Chai C. Bao Q, et al. Sci Rep. 2024 Jan 29;14(1):2391. doi: 10.1038/s41598-023-50510-9. Sci Rep. 2024. PMID: 38287040 Free PMC article.
References
- Cell Stem Cell. 2009 Jul 2;5(1):111-23 - PubMed
- Cell. 2006 Aug 25;126(4):663-76 - PubMed
- Nature. 2004 Mar 4;428(6978):44-9 - PubMed
- Nature. 2009 Jul 2;460(7251):49-52 - PubMed
- Science. 2002 Feb 1;295(5556):868-72 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials